Investing.com - Ideaya Biosciences Inc reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Ideaya Biosciences Inc announced earnings per share of $0.04 on revenue of $29.7M. Analysts polled by Investing.com EPS of $-0.61 on revenue of $7.97M.
Ideaya Biosciences Inc 's are down 35% and is trading at $18.16 , still down 26.51% from its 52 week high of $24.71 set on Monday, November 22, 2021.
Ideaya Biosciences Inc shares gained 3.30% to trade at $18.16 in intra-day trade the report.
Ideaya Biosciences Inc follows other major Healthcare sector earnings this month
Ideaya Biosciences Inc's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar